Total Payments
$4,096
2024 Payments
$479.62
Companies
28
Transactions
145
Medicare Patients
10,727
Medicare Billing
$662,926

Payment Breakdown by Category

Food & Beverage$2,168 (52.9%)
Consulting$1,500 (36.6%)
Education$413.13 (10.1%)
Travel$15.42 (0.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,168 104 52.9%
Consulting Fee $1,500 1 36.6%
Education $413.13 38 10.1%
Travel and Lodging $15.42 2 0.4%

Top Paying Companies

Company Total Records Latest Year
Allergan Inc. $1,515 3 $0 (2017)
Janssen Biotech, Inc. $320.03 10 $0 (2024)
E.R. Squibb & Sons, L.L.C. $262.91 8 $0 (2024)
MAYNE PHARMA INC. $261.44 21 $0 (2022)
Amgen Inc. $208.36 15 $0 (2024)
UCB, Inc. $157.99 6 $0 (2024)
Galderma Laboratories, L.P. $154.39 6 $0 (2022)
Taro Pharmaceuticals USA, Inc. $141.66 34 $0 (2018)
Novartis Pharmaceuticals Corporation $134.84 5 $0 (2022)
ABBVIE INC. $128.90 7 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $479.62 20 UCB, Inc. ($157.99)
2023 $402.87 20 E.R. Squibb & Sons, L.L.C. ($155.57)
2022 $452.49 18 Galderma Laboratories, L.P. ($154.39)
2021 $39.38 2 Lilly USA, LLC ($27.12)
2020 $33.19 2 MAYNE PHARMA INC. ($20.69)
2019 $379.00 25 Mayne Pharma Inc. ($194.90)
2018 $526.02 43 Taro Pharmaceuticals USA, Inc. ($141.66)
2017 $1,784 15 Allergan Inc. ($1,515)

All Payment Transactions

145 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/19/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $19.00 General
Category: Immunology
12/11/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $19.07 General
Category: Immunology
11/01/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $18.74 General
Category: Immunology
10/26/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $45.95 General
Category: Immunology
10/22/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $2.31 General
Category: Immunology
10/04/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $16.93 General
Category: Inflammation
08/02/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Food and Beverage In-kind items and services $20.06 General
Category: Dermatology
08/01/2024 PFIZER INC. CIBINQO (Drug) Food and Beverage In-kind items and services $25.88 General
Category: Inflammation & Immunology
08/01/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $4.34 General
Category: Immunology
06/13/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $129.16 General
Category: Immunology
05/23/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $13.86 General
Category: Inflammation
05/15/2024 SUN PHARMACEUTICAL INDUSTRIES INC. Education In-kind items and services $47.99 General
05/13/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $6.75 General
Category: Immunology
05/03/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Food and Beverage In-kind items and services $27.08 General
Category: Dermatology
05/02/2024 Organogenesis Inc. Food and Beverage In-kind items and services $21.52 General
04/17/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $13.55 General
Category: IMMUNOLOGY
03/14/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $15.87 General
Category: Inflammation
02/29/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $8.63 General
Category: Immunology
02/15/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $6.80 General
Category: Immunology
01/25/2024 MAYNE PHARMA COMMERCIAL LLC Food and Beverage In-kind items and services $16.13 General
12/21/2023 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $16.10 General
Category: Inflammation
12/14/2023 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $22.72 General
Category: DERMATOLOGY
12/01/2023 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $13.84 General
Category: Inflammation
11/30/2023 Arcutis Biotherapeutics, Inc. Food and Beverage In-kind items and services $16.67 General
11/10/2023 Genentech USA, Inc. Xolair (Biological) Food and Beverage In-kind items and services $16.49 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 2,913 5,841 $428,472 $184,558
2022 12 2,851 6,146 $425,767 $180,835
2021 13 2,572 5,328 $375,076 $164,518
2020 13 2,391 4,859 $350,455 $133,014
Total Patients
10,727
Total Services
22,174
Medicare Billing
$662,926
Procedure Codes
50

All Medicare Procedures & Services

50 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 1,019 1,434 $143,400 $79,847 55.7%
17000 Destruction of precancer skin growth, 1 growth Office 2023 671 933 $107,295 $35,968 33.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 188 201 $31,155 $16,171 51.9%
17110 Destruction of skin growth, 1-14 growths Office 2023 192 209 $33,440 $16,007 47.9%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 494 2,701 $59,422 $11,833 19.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 148 148 $20,720 $9,477 45.7%
11102 Biopsy of related skin growth, first growth Office 2023 108 117 $17,550 $7,536 42.9%
17281 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm Office 2023 16 16 $4,160 $2,162 52.0%
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm Office 2023 17 18 $4,590 $2,120 46.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 37 41 $2,870 $1,414 49.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 12 12 $2,220 $1,205 54.3%
10040 Acne surgery Office 2023 11 11 $1,650 $818.15 49.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 992 1,440 $143,935 $78,920 54.8%
17000 Destruction of precancer skin growth, 1 growth Office 2022 655 924 $106,260 $37,523 35.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 259 259 $36,260 $17,057 47.0%
17003 Destruction of precancer skin growth, 2-14 growths Office 2022 522 3,069 $67,518 $13,722 20.3%
17110 Destruction of skin growth, 1-14 growths Office 2022 121 141 $22,499 $10,077 44.8%
11102 Biopsy of related skin growth, first growth Office 2022 116 121 $18,150 $7,994 44.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 69 71 $11,005 $6,323 57.5%
17281 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm Office 2022 22 23 $5,980 $2,985 49.9%
17004 Destruction of precancer skin growth, 15 or more growths Office 2022 16 16 $4,480 $1,907 42.6%
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm Office 2022 19 19 $3,990 $1,731 43.4%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 44 47 $3,290 $1,682 51.1%
10040 Acne surgery Office 2022 16 16 $2,400 $914.50 38.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 916 1,325 $132,500 $76,153 57.5%

About Dr. Andrew John, M.D

Dr. Andrew John, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Edmond, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2010. The National Provider Identifier (NPI) number assigned to this provider is 1609193614.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew John, M.D has received a total of $4,096 in payments from pharmaceutical and medical device companies, with $479.62 received in 2024. These payments were reported across 145 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,168).

As a Medicare-enrolled provider, John has provided services to 10,727 Medicare beneficiaries, totaling 22,174 services with total Medicare billing of $662,926. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.

Practice Information

Products in Payments

  • RHOFADE (Drug) $1,515
  • Sotyktu (Drug) $262.91
  • Tremfya (Drug) $247.39
  • DORYX (Drug) $215.59
  • Otezla (Drug) $208.36
  • Bimzelx (Biological) $157.99
  • COSENTYX (Biological) $134.84
  • DUPIXENT (Drug) $116.33
  • OPZELURA (Drug) $99.68
  • SILIQ (Drug) $92.83
  • DUPIXENT DUPILUMAB INJECTION (Biological) $89.52
  • ILUMYA (Biological) $69.79
  • Humira (Biological) $66.41
  • EPSOLAY (Drug) $64.60
  • TREMFYA (Drug) $55.34
  • HALOG (Halcinonide Cream, USP) 0.1% (Drug) $53.34
  • TALTZ (Drug) $53.15
  • RINVOQ (Biological) $48.94
  • TOPICORT (desoximetasone) Topical Spray, 0.25% (Drug) $42.24
  • CIBINQO (Drug) $25.88

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Edmond